Halt Medical said today that it won coverage from Blue Cross Blue Shield of South Carolina for procedures using its Acessa System to remove fibroids.
Acessa uses radiofrequency ablation guided by ultrasound to remove fibroids, which are benign, non-cancerous tumors that occur in women’s uteri, often during childbearing years, Halt Medical said.
The Brentwood, Calif.-based company touted the reimbursement win, saying that BCBS covers nearly 1 million individuals and is the largest private insurer in South Carolina.
Halt Medical said that the American Medical Association recently granted a category 1 CPT code specifically for laparoscopic radiofrequency uterine fibroid ablation procedures, with the code going live on January 1st.
“BCBS of South Carolina joins HCSC as well as BCBS of MI, Aetna, TriCare, along with a growing list of leading-edge private insurers to provide coverage for Acessa. This positive coverage decision expands access to patients who desire an alternative to more invasive approaches,” prez & CEO Kim Bridges said in a press release.
In July, Halt Medical said that it won coverage for the Acessa from Blue Cross Blue Shield of Michigan.
Acessa is already covered by Aetna, Health Care Services Corporation, Health Alliance Plan of Michigan, Coventry and other insurance groups, Halt Medical said.
Last April, Halt Medical listed more than $92.8 million raised in a pair of funding rounds, used to restructure some existing debt and fund U.S. commercial efforts, the company said.